Foghorn Therapeutics Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Foghorn Therapeutics Inc. (FHTX) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$628.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- Foghorn Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$719.00K.
- Foghorn Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $91.00K.
- Foghorn Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $501.00K, a 59.50% decline year-over-year.
- Foghorn Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$1.34M.
- Foghorn Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$2.83M.
- Foghorn Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$1.32M.
- Foghorn Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$741.00K, a 341.37% decline from fiscal 2022.
- Foghorn Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $307.00K, a 83.08% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$719.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$628.00K 10-Q · filed 2026-08-06 | -$127.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $91.00K 10-Q · filed 2026-05-07 | $592.00K derived: sum of 2 quarters · filed 2026-05-07 | -$747.00K derived: sum of 3 quarters · filed 2026-05-07 | -$1.67M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $501.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$838.00K derived: sum of 2 quarters · filed 2026-03-11 | -$1.76M derived: sum of 3 quarters · filed 2026-08-06 | -$2.83M 10-K · filed 2026-03-11 |
| 2025-09-30 | -$1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$2.26M derived: sum of 2 quarters · filed 2026-08-06 | -$3.33M 10-Q · filed 2025-11-05 | -$2.09M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$920.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.99M 10-Q · filed 2026-08-06 | -$752.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.51M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$1.07M 10-Q · filed 2026-05-07 | $168.00K derived: sum of 2 quarters · filed 2026-05-07 | -$593.00K derived: sum of 3 quarters · filed 2026-05-07 | -$1.06M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $476.00K derived: sum of 2 quarters · filed 2026-03-11 | $11.00K derived: sum of 3 quarters · filed 2026-03-11 | -$1.32M 10-K · filed 2026-03-11 |
| 2024-09-30 | -$761.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.23M derived: sum of 2 quarters · filed 2025-11-05 | -$2.55M 10-Q · filed 2025-11-05 | -$2.00M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$465.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$1.79M 10-Q · filed 2025-08-05 | -$1.24M derived: sum of 3 quarters · filed 2025-08-05 | -$1.91M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | -$1.33M 10-Q · filed 2025-05-14 | -$772.00K derived: sum of 2 quarters · filed 2025-05-14 | -$1.44M derived: sum of 3 quarters · filed 2025-05-14 | -$1.18M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $556.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$115.00K derived: sum of 2 quarters · filed 2025-03-06 | $146.00K derived: sum of 3 quarters · filed 2025-03-06 | -$741.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | -$671.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | -$410.00K derived: sum of 2 quarters · filed 2024-11-04 | -$1.30M 10-Q · filed 2024-11-04 | $78.00K derived: sum of 4 quarters · filed 2024-11-04 |
| 2023-06-30 | $261.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$626.00K 10-Q · filed 2024-08-08 | $749.00K derived: sum of 3 quarters · filed 2024-08-08 | -$360.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$887.00K 10-Q · filed 2024-05-06 | $488.00K derived: sum of 2 quarters · filed 2024-05-06 | -$621.00K derived: sum of 3 quarters · filed 2024-05-06 | -$396.00K derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $266.00K derived: sum of 2 quarters · filed 2024-03-07 | $491.00K derived: sum of 3 quarters · filed 2024-03-07 | $307.00K 10-K · filed 2024-03-07 |
| 2022-09-30 | -$1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$884.00K derived: sum of 2 quarters · filed 2023-11-02 | -$1.07M 10-Q · filed 2023-11-02 | $1.06M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $225.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $41.00K 10-Q · filed 2023-08-04 | $2.17M derived: sum of 3 quarters · filed 2023-08-04 | $1.77M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | -$184.00K 10-Q · filed 2023-05-08 | $1.95M derived: sum of 2 quarters · filed 2023-05-08 | $1.54M derived: sum of 3 quarters · filed 2023-05-08 | $1.33M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $1.73M derived: sum of 2 quarters · filed 2023-03-09 | $1.52M derived: sum of 3 quarters · filed 2023-03-09 | $1.81M 10-K · filed 2023-03-09 |
| 2021-09-30 | -$403.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$611.00K derived: sum of 2 quarters · filed 2022-11-08 | -$316.00K 10-Q · filed 2022-11-08 | $2.63M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$208.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $87.00K 10-Q · filed 2022-08-09 | $3.03M derived: sum of 3 quarters · filed 2022-08-09 | $3.98M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $295.00K 10-Q · filed 2022-05-09 | $3.24M derived: sum of 2 quarters · filed 2022-08-09 | $4.19M derived: sum of 3 quarters · filed 2022-08-09 | $4.90M derived: sum of 4 quarters · filed 2022-08-09 |
| 2020-12-31 | $2.94M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-08-09 | $3.90M derived: sum of 2 quarters · filed 2022-08-09 | $4.61M derived: sum of 3 quarters · filed 2022-08-09 | $4.67M 10-K/A · filed 2022-08-09 |
| 2020-09-30 | $951.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.66M derived: sum of 2 quarters · filed 2021-11-09 | $1.73M 10-Q · filed 2021-11-09 | $2.21M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $710.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $774.00K 10-Q · filed 2021-08-10 | $1.26M derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | $64.00K 10-Q · filed 2021-05-11 | $548.00K derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $484.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $991.00K 10-K · filed 2021-03-18 | ||
| 2019-09-30 | $507.00K 10-Q · filed 2020-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |